UBS Sees Modest Improvement In Apple Wait Times

UBS analyst David Vogt keeps his Buy rating and $175 price target on Apple Inc AAPL, implying a 5.9% upside.
Vogt stated that data from UBS Evidence Lab suggest that while wait times for the company's highest-priced iPhone 13 Pro Max in all of the critical regions remain elevated, they also see some "modest improvement."
Vogt adds that the decline in wait times coincides with improvements in the supply chain as some of the earlier headwinds appear to have been resolved, with several suppliers noting that December production should be better than November.
Related Content: Read Why Apple Was Up On November 30 With Broader Markets In Red
Price Action: AAPL shares traded higher by 1.16% at $167.21 in the premarket session on the last check Wednesday.

Overview Rating:

Good

0100

Analyst Calendar